Dr James M Cooper, MD | |
519 E Main St, Cut Bank, MT 59427-3015 | |
(406) 873-5670 | |
(406) 873-5675 |
Full Name | Dr James M Cooper |
---|---|
Gender | Male |
Speciality | Obstetrics & Gynecology |
Location | 519 E Main St, Cut Bank, Montana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497860183 | NPI | - | NPPES |
0149889 | Medicaid | MT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 6727 (Montana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr James M Cooper, MD 519 E Main St, Cut Bank, MT 59427-3015 Ph: (406) 873-5670 | Dr James M Cooper, MD 519 E Main St, Cut Bank, MT 59427-3015 Ph: (406) 873-5670 |
News Archive
Research at the Babraham Institute, investigating how white blood cells known as B cells develop, has revealed that genes from the Phosphatidylinositol 3-kinase family of enzymes are critical in enabling the B cells to produce antibodies in the spleen and lymph nodes.
Global Technology Resources, Inc., a Colorado-based I.T. integration consulting group, has announced a formal agreement with one of its strategic partners, VeriWave Inc., making GTRI one of only a handful of Gold Certified Partners in the country. By being a Gold Certified Partner, this gives GTRI the ability to advance its healthcare professional services offerings to the next level.
Astellas US LLC, a United States (U.S.) subsidiary of Tokyo-based Astellas Pharma Inc., and Medivation, Inc. today announced that results from the STRIVE trial of enzalutamide compared to bicalutamide in men with castration-resistant prostate cancer (CRPC) were published in the Journal of Clinical Oncology.
Patients accessing health care services across Pennsylvania will soon benefit from fewer duplicative diagnostic tests, faster retrieval of clinical information, stronger safety measures and better coordination of care – all via a new IT platform that enables the sharing of patient information across multiple health care systems.
CANCER RESEARCH UK scientists have discovered how mistakes in a key gene drive the early stages of aggressive ovarian cancers. This could improve diagnosis of aggressive forms of the disease and lead to new treatments, according to a study published in the Journal of Pathology this month.
› Verified 2 days ago